Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30
Coronavirus FAQs
Questions about cover for coronavirus? Read our FAQs and find out what our policies can do for you. If you would like to contact us, please note we are currently only available 09:00 to 17:30 Monday to Friday due to reduced operational capacity. Thank you.
17 November 2017 09:18
It's estimated 8,000 women could benefit from the drugs
Women diagnosed with untreatable breast cancer are being given fresh hope, with the approval of two new "breakthrough" medicines for widespread use across England's health service.
The National Institute for Health and Care Excellence (Nice) has approved NHS use of palbociclib and ribociclib - drugs that are shown to slow down advance cancer and delay the need for chemotherapy.
Nice - which has rejected palbociclib in the past because of its high cost - has announced the new agreement after negotiating a new lower price with manufactured Pfizer.
A life-changing breakthrough
Around 45,000 women receive new diagnoses of breast cancer each year in England, and it's estimated 8,000 women could benefit from the ground-breaking treatment.
Nicholas Turner, trial lead and professor of molecular oncology at the Institute of Cancer Research (ICR) in London and consultant medical oncologist at the Royal Marsden, says: "The development of this brand new class of cancer drug is one of the most important breakthroughs for women with advanced breast cancer in the last two decades.
"In clinical trials, palbociclib and ribociclib have made a huge difference to women's lives - slowing down tumour growth for nearly a year, and delaying the need for chemotherapy with all its potentially debilitating side-effects. These drugs have allowed women to live a normal life for longer."
Treatment for women of any age
Women who are pre-menopausal and have been diagnosed with oestrogen receptor positive breast cancer after it the disease has spread will be eligible for palbociclib.
Post-menopausal women diagnosed who are diagnosed under the same conditions will be treated with ribociclib, manufactured by Novartis.
Both drugs work in a similar way, and are shown to hold back breast cancer for at least 10 months, affording women a normal life for longer.
Even if your cancer has spread, if you have had chemotherapy in the last three months, are taking strong painkillers or have a terminal prognosis, we may still be able to cover you for holidays and overseas travel with our specialist cancer travel insurance.
09 March 2020
Move over hot cross buns and chocolate eggs, there's a whole world of Easter treats out there. Here are some alternative Easter foods from around the world.
[more...]
Forget egg hunts and bunnies, Easter's done a little bit differently in these corners of the world. Here five alternative Easter celebrations.
28 February 2020
Keep your carbon footprint in check and travel green with our eco-friendly travel tips.
25 February 2020
For true carefree travel, decide on a destination that's kinder to the planet...
20 February 2020
Travel into the future and not just through time-zones, with destinations shaping urban living.
National Anthem Day falls on the 3rd March, so what better excuse is there to delve into into the world of music and motherland?
Discover five alternative places to get down on one knee this leap year.
Two-wheels are better than none. Check out our favourite cities best explored from a saddle.
04 February 2020
Make your phone the perfect travel companion for the new year...
Bohemian boulevards and ornate opera houses await away from the Six Nations action.
Kite Flying Day falls on 8th February. What better time is there to plan your next trip through the skies?
10 February 2020
With Ferris Wheel Day on 14th February, there's never been a better excuse to enjoy a foreign skyline.